Eureka Therapeuticsincis A Clinical Stage Biotechnology Company Based In The San Francisco Bay Areathe Company Focuses On Developing Innovative Immunotherapies For Cancer Treatmentutilizing Proprietary Technologies To Advance T Cell Therapies And Novel Antibody Immunotherapiestheir Mission Is To Harness The Human Immune System To Improve The Lives Of Cancer Patients The Company Is Actively Developing T Cell Therapies Aimed At Curing Solid Tumors And Is Recognized For Its Work In Discovering Novel Antibody Immunotherapieseureka Therapeutics Collaborates With Notable Partnersincluding Novartis And Memorial Sloan Kettering Cancer Centerto Enhance Its Research And Development Effortsthey Also Have A Licensing Agreement With The National Cancer Institute To Develop Gpc2 Artemis T Cell Therapy For Neuroblastomawith A Dedicated Team Of 51 To 200 Employeeseureka Therapeutics Is Committed To Advancing Its Innovative Approaches In The Biotechnology Sector
